CDKN2A and retinoblastoma: Genome-wide profiling further reveals dozens of hypermethylated tumor suppressors (e.g., RB1, CDKN2A, RASSF1A, MLH1, etc.), reinforcing the idea of epigenetic cooperativity in retinoblastoma pathogenesis [39].